Galetin, Aleksandra http://orcid.org/0000-0002-3933-5217
Brouwer, Kim L. R. http://orcid.org/0000-0003-1945-4929
Tweedie, Donald
Yoshida, Kenta http://orcid.org/0000-0003-4967-3831
Sjöstedt, Noora http://orcid.org/0000-0001-6960-7757
Aleksunes, Lauren http://orcid.org/0000-0002-0032-1037
Chu, Xiaoyan
Evers, Raymond
Hafey, Michael J.
Lai, Yurong http://orcid.org/0000-0001-9505-333X
Matsson, Pär http://orcid.org/0000-0002-9094-2581
Riselli, Andrew http://orcid.org/0000-0002-0714-5726
Shen, Hong
Sparreboom, Alex
Varma, Manthena V. S.
Yang, Jia http://orcid.org/0000-0002-3992-4070
Yang, Xinning
Yee, Sook Wah http://orcid.org/0000-0001-8121-8746
Zamek-Gliszczynski, Maciej J.
Zhang, Lei http://orcid.org/0000-0002-0639-3162
Giacomini, Kathleen M. http://orcid.org/0000-0001-8041-5430
Article History
Accepted: 12 December 2023
First Online: 24 January 2024
Competing interests
: A.G. is a deputy director of the Centre for Applied Pharmacokinetic Research, which is a consortium of companies including Genentech, Roche, Merck Serono, Takeda, Janssen, GSK, Servier, Amgen, Eli Lilly and Abbvie. She receives funding from A*STAR (BM/NDR/19/003), Research Council of Norway (15451500) and Asahi Kasei Pharma Corporation for her PhD students and trainees, and she is an unpaid President of the International Society for the Study of Xenobiotics. D.T. owns stock and/or stock options in Merck & Co., Inc. and receives free membership in the International Society for the Study of Xenobiotics. H.S. is an employee of Bristol Myers Squibb and owns stock and/or stock options in Bristol Myers Squibb. K.L.R.B. is co-inventor of the sandwich-cultured hepatocyte technology for quantification of biliary excretion (B-CLEAR) and related technologies, which have been licensed exclusively to Qualyst Transporter Solutions, acquired by BioIVT. She receives funding from a Certara Simcyp Grant and Partnership Scheme to support a PhD student in her laboratory and serves as an unpaid member of the scientific advisory committee for the International Society for the Study of Xenobiotics. K.Y. is an employee of Genentech and owns stock and/or stock options in Genentech and Roche. L.A. serves in an unpaid position for the Society of Toxicology. M.J.H. and X.C. are employees of Merck & Co., Inc. and own stock and/or stock options in Merck & Co., Inc. M.J.Z.-G. is an employee of GlaxoSmithKline and owns stock and/or stock options in GlaxoSmithKline. He also serves in an unpaid position for the American Society for Clinical Pharmacology and Therapeutics. M.V.S.V is an employee of Pfizer and owns stock and/or stock options in Pfizer. N.S. receives funding for graduate student support from the Sigrid Jusélius Foundation. R.E. is an employee of Johnson & Johnson and owns stock and/or stock options in Johnson & Johnson. Y.L. is an employee of Gilead Sciences, Inc. and owns stock and/or stock options in Gilead Sciences, Inc. K.M.G. and S.W.Y. are co-founders of Apricity Therapeutics, Inc., a transporter-based biotechnology company. A.R., J.Y., L.Z., P.M. and X.Y. declare no competing interests.